Dr. Mark Socinski, MD
Claim this profileAdventHealth Orlando
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
9 reported clinical trials
11 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
HER2 positive
2Lung Cancer
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Mark Socinski, MD is currently running
Zipalertinib
for Non-Small Cell Lung Cancer
This trial is testing CLN-081, a new drug, in patients with a specific type of lung cancer that has a genetic mutation. The drug aims to block a protein that helps cancer cells grow, to see if it can slow down or stop the cancer.
Recruiting1 award Phase 1 & 23 criteria
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
More about Mark Socinski, MD
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Mark Socinski, MD has experience with
- ONC-392
- Docetaxel
- Seribantumab
- Atezolizumab
- CLN-081
- ELVN-002
Breakdown of trials Mark Socinski, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Socinski, MD specialize in?
Mark Socinski, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mark Socinski, MD currently recruiting for clinical trials?
Yes, Mark Socinski, MD is currently recruiting for 5 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Mark Socinski, MD has studied deeply?
Yes, Mark Socinski, MD has studied treatments such as ONC-392, Docetaxel, Seribantumab.
What is the best way to schedule an appointment with Mark Socinski, MD?
Apply for one of the trials that Mark Socinski, MD is conducting.
What is the office address of Mark Socinski, MD?
The office of Mark Socinski, MD is located at: AdventHealth Orlando, Orlando, Florida 32806 United States. This is the address for their practice at the AdventHealth Orlando.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.